MX2016007295A - Composicion para reducir trastornos de envejecimiento de la piel que comprenden un retinaldehido y un extracto de leontopodium alpinum. - Google Patents

Composicion para reducir trastornos de envejecimiento de la piel que comprenden un retinaldehido y un extracto de leontopodium alpinum.

Info

Publication number
MX2016007295A
MX2016007295A MX2016007295A MX2016007295A MX2016007295A MX 2016007295 A MX2016007295 A MX 2016007295A MX 2016007295 A MX2016007295 A MX 2016007295A MX 2016007295 A MX2016007295 A MX 2016007295A MX 2016007295 A MX2016007295 A MX 2016007295A
Authority
MX
Mexico
Prior art keywords
retinaldehyde
composition
reducing skin
skin ageing
leontopodium alpinum
Prior art date
Application number
MX2016007295A
Other languages
English (en)
Inventor
Baudier Philippe
Original Assignee
Galephar M/F
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galephar M/F filed Critical Galephar M/F
Publication of MX2016007295A publication Critical patent/MX2016007295A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/11—Aldehydes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Birds (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente invención se refiere a una composición para reducir los trastornos de envejecimiento de la piel, que comprende al menos un retinaldehído y/o uno de sus estereoisómeros y al menos un extracto de Leontopodium alpinum en un vehículo cosmética y farmacéuticamente aceptable.
MX2016007295A 2013-12-03 2014-12-03 Composicion para reducir trastornos de envejecimiento de la piel que comprenden un retinaldehido y un extracto de leontopodium alpinum. MX2016007295A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1362015 2013-12-03
PCT/EP2014/076356 WO2015082520A1 (fr) 2013-12-03 2014-12-03 Composition pour reduire les troubles de la senescence cutanee comprenant un rétinalaldéhyde et un extrait de leontopodium alpinum

Publications (1)

Publication Number Publication Date
MX2016007295A true MX2016007295A (es) 2017-01-05

Family

ID=50289873

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016007295A MX2016007295A (es) 2013-12-03 2014-12-03 Composicion para reducir trastornos de envejecimiento de la piel que comprenden un retinaldehido y un extracto de leontopodium alpinum.

Country Status (9)

Country Link
EP (1) EP3077061B1 (es)
KR (1) KR20160103983A (es)
BR (1) BR112016012671A2 (es)
ES (1) ES2791066T3 (es)
MX (1) MX2016007295A (es)
PH (1) PH12016501013A1 (es)
RU (1) RU2675702C1 (es)
WO (1) WO2015082520A1 (es)
ZA (1) ZA201603801B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018077991A1 (en) * 2016-10-27 2018-05-03 Dsm Ip Assets B.V. Method of protecting keratinocytes against the harmful effects of air pollution
JPWO2019022250A1 (ja) * 2017-07-28 2020-07-09 国立大学法人九州大学 水溶性有効成分の放出が制御された経皮吸収組成物
KR102116482B1 (ko) * 2020-02-27 2020-05-28 주식회사 한국화장품제조 안티폴루션 유화물이 담지된 화장료 조성물 및 이의 제조방법

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2782919B1 (fr) * 1998-09-04 2001-05-25 Roc Sa Composition contre le vieillissement et son utilisation
CH694611A5 (de) * 2000-05-16 2005-04-29 Pentapharm Ag Kosmetisch wirksame Zusammensetzung.
JP2002138027A (ja) * 2000-10-27 2002-05-14 Kose Corp 皮膚外用剤
US9155915B2 (en) * 2009-07-27 2015-10-13 Dermadoctor, Inc. Moisturizing retinol composition
US8410079B2 (en) * 2010-08-06 2013-04-02 Island Kinetics Chirally correct retinal cyclodextrin hemiacetals for clarifying skin complexion
EP2522330A1 (en) * 2011-05-09 2012-11-14 DSM IP Assets B.V. Use of resveratrol and an edelweiss extract
FR2980361B1 (fr) * 2011-09-28 2013-10-25 Dermatologiques Uriage Lab Composition cosmetique et/ou dermatologique pour maintenir ou regenerer les qualites physiques, optiques, mecaniques ou biochimiques de la peau

Also Published As

Publication number Publication date
KR20160103983A (ko) 2016-09-02
RU2675702C1 (ru) 2018-12-24
ZA201603801B (en) 2017-07-26
ES2791066T3 (es) 2020-10-30
PH12016501013A1 (en) 2016-07-04
BR112016012671A2 (pt) 2017-08-08
EP3077061B1 (fr) 2020-03-18
EP3077061A1 (fr) 2016-10-12
WO2015082520A1 (fr) 2015-06-11

Similar Documents

Publication Publication Date Title
HK1225623A1 (zh) 用於診斷和治療與表達cd206的細胞相關的病症的組合物、方法和藥盒
MX2015015249A (es) Peptidos terapeuticos.
AU357122S (en) Headgear for patient interface
EP3046470A4 (en) Diagnosing and treating movement disorders
WO2014138429A3 (en) Peptidomimetic macrocycles and use thereof in regulating hif1alpha
EP3038474A4 (en) Nutraceutical combination for prevention and treatment of type 2 diabetes
EP3057514A4 (en) Formulations and methods for increasing or reducing mucus
PL3538066T3 (pl) Wypełniacze skórne z kwasem hialuronowym usieciowane kwasem cytrynowym, sposób ich wytwarzania i ich zastosowania
SI2968471T1 (sl) Peptidi za uporabo pri lokalnem zdravljenju nevrodegenerativnih bolezni mrežnice, zlasti v zgodnjih fazah diabetične retinopatije in drugih bolezni mrežnice, pri katerih igra nevrodegeneracija bistveno vlogo
WO2013183058A3 (en) Expanded device
HK1216866A1 (zh) 含有富含類胡蘿蔔素的運動節桿菌提取物的化妝品、藥物或食品組合物
EP2947143A4 (en) RECOMBINANT CELL, AND PROCESS FOR PRODUCING 1,4-BUTANEDIOL
EP3061455A4 (en) Therapeutic agent for ocular disease or prophylactic agent for ocular disease
EP3145568A4 (en) Device to reduce discomfort in the upper airway
EP3086846A4 (en) Diagnosing and treating alzheimer's disease
PH12016501013A1 (en) Composition for reducing skin ageing disorders, comprising a retinaldehyde and a leontopodium alpinum extract
EP2991733A4 (en) Cannabidiol for the prevention and treatment of graft-versus-host disease
EP3044321A4 (en) New marker for the classification, diagnosis and treatment of scoliosis
GB2541318A (en) Use of undaria extract to reduce signs of skin aging
EP2968222A4 (en) METHOD, COMPOSITIONS AND DEVICES FOR TREATING MOTOR DISTURBANCES AND DEPRESSION SYMPTOMS RELATED TO MORBUS PARKINSON
WO2014166502A3 (en) Use of immune suppressive domains as medicaments
PH12017501979A1 (en) Pharmaceutical compound
EP2970349A4 (en) Carbohydrate-modified glycoproteins and uses thereof
EP3310308A4 (en) EYE LIGHT PENDANT AND RELATED METHODS
WO2014144017A3 (en) Compositions and methods for treating conditions that affect epidermis

Legal Events

Date Code Title Description
FG Grant or registration